Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2021

View Archived Issues

Recombinant hemagglutinin-expressing HSV vector offers protection against both HSV and influenza

Compound inhibits acute myeloid leukemia cells with FLT3-ITD mutations by targeting HSP70

Aston University descibres new antibacterials

New antivirals presented by EcoSynth, Transmare Chemie

Leiden University and collaborators patent monoglyceride lipase inhibitors

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

APMAP identified as a regulator of cancer cell phagocytosis

Kynurenine metabolites as biomarkers of chronic fatigue syndrome and fibromyalgia

Primate model of autism spectrum disorder reveals potential therapeutic targets

Identification of novel viral cleavage sites and potential therapeutic targets against SARS-CoV-2

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Different way of looking allows new insights into cancer biology

Elastase inhibition enhances the adjuvant activity of alum for SARS-CoV-2 vaccination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...